ORMP Oramed Pharmaceuticals Inc. - Common Stock
$4,83
Prezzo · Ago 19, 2026
Fondamentali al Ago 10, 2026
Intervallo 52 sett.
$2–$5
89% of range
Rating Analisti
HOLD
6 analysts
Prezzo Obiettivo
$6
+29% upside
P/E (TTM)
0.0
ROE
37.0%
Margine di Profitto Netto
3202.5%
Informazioni su Oramed Pharmaceuticals Inc. - Common Stock Panoramica della società da Wikipedia
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
Leggi di più
Oramed Pharmaceuticals Inc. (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
History
Oramed Pharmaceuticals was founded in 2006 by Miriam Kidron, a scientist at the Hadassah University Hospital in Jerusalem, and her son Nadav Kidron.
Product pipeline
Oramed considers its flagship product to be an oral insulin capsule developed to treat sufferers of type 2 diabetes. The Company is currently conducting Phase 3 trials, under the FDA, for oral insulin in Type 2 diabetes.
In addition to the oral insulin capsule, Oramed is developing an exenatide-based capsule designed to balance blood sugar levels and control appetite, and is conducting clinical trials for the treatment of NASH with oral insulin.
In 2021, Oramed created a subsidiary, Oravax Medical, to bring an oral Covid-19 vaccine to market.
In January 2023, a Phase 3 trial of Oramed's orally administered insulin for Type 2 diabetes patients failed, thus causing the share price to plunge. The company has mentioned that the pill worked for a subset of the population and will pursue a Phase 3 trial for that subset.
In May 2023, Ben Shapiro invested $4.7 million and was named to the board of directors.
On May 15, 2023, it was reported that Oramed's insulin pill was approved in China and will work with a Chinese firm to apply for marketing authorizations.
Subsidiaries
OraTech Pharmaceuticals is a joint venture formed by Oramed Pharmaceuticals and Hefei Tianhui Biotech, to commercialize its insulin capsule and is expected to list on the NASDAQ sometime in 2025.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
ORMP Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$4.83
Capitalizzazione di Mercato
$197.7K
P/E (TTM)
0.0
EPS (TTM)
$1.50
Ricavi (TTM)
$2M
Rendimento div.
—
ROE
37.0%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$2 – $5
ORMP Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$2M
2017-08-31
→
2025-12-31
EPS
$1.50
2022-12-31
→
2025-12-31
Flusso di cassa libero
$-9M
2019-08-31
→
2025-12-31
Margini
3202.5%
2025-12-31
→
2025-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
ORMP
Mediana dei peer
P/E (TTM)
0.0
23.4
P/S (TTM)
0.1
11.2
P/B
0.0
2.5
Price / FCF (Prezzo / FCF)
-0.0
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
ORMP
Mediana dei peer
Gross Margin (Margine lordo)
0.65%
82.8%
Operating Margin (Margine Operativo)
-754.4%
—
Net Profit Margin (Margine di Profitto Netto)
3202.5%
-199.7%
ROA
33.2%
-34.8%
ROE
37.0%
-33.2%
ROIC
-6.4%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
ORMP
Mediana dei peer
Current Ratio (Rapporto corrente)
7.0
1.5
Quick Ratio
2.7
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
ORMP
Mediana dei peer
Revenue YoY (Ricavi YoY)
-50.4%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
-9.6%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
ORMP
Mediana dei peer
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Dividend Yield
—
Rapporto di Distribuzione Utili
—
CAGR Dividendi 5Y
—
| Data ex-dividendo | Importo |
|---|---|
| 16 Gennaio 2026 | $0,2500 |
ORMP Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
VENDI
6 analisti
- Acquisto forte 0 0,0%
- Compra 0 0,0%
- Mantieni 3 50,0%
- Vendi 1 16,7%
- Vendita forte 2 33,3%
Target Price a 12 Mesi
1 analisti · 2026-08-17
Basso
$6.25
Alto
$6.25
Target mediano
$6.25
+29,4%
Target medio
$6.25
+29,4%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.32%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Dicembre 2025 | $0.24 | $0.00 | 0.24% |
| 30 Settembre 2025 | $1.12 | $-0.04 | 1.2% |
| 30 Giugno 2025 | $0.31 | $-0.04 | 0.35% |
| 31 Marzo 2025 | $-0.19 | $-0.01 | -0.18% |
| 31 Dicembre 2024 | $0.00 | $-0.03 | 0.03% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| TTRX | $116M | -32.8 | — | — | -141.7% | — |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | — |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| NRXP | — | — | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | · | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Cost of Revenue | $2M | · | · | · | · | · | $90.0K | $-86.0K | $187.0K | |
| Gross Profit | $13.0K | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $6M | $9M | $28M | · | $10M | $14M | $12M | $10M | |
| SG&A Expense | $9M | $6M | $8M | $14M | · | $4M | $4M | $4M | $3M | |
| Operating Income | $-15M | $-13M | $-16M | $-41M | · | $-12M | $-15M | $-14M | $-11M | |
| Interest Expense | · | · | $2M | · | · | · | · | · | · | |
| Interest Income | · | · | $10.0K | · | · | · | · | · | · | |
| Other Non-op | $-606.0K | $-27.0K | $13.3K | $3M | · | · | · | · | · | |
| Pretax Income | $75M | $-16M | $5M | $-38M | · | $-12M | $-14M | $-13M | $-10M | |
| Income Tax | $11M | $3M | · | $100.0K | · | · | $300.0K | · | $400.0K | |
| Net Income | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| EPS (Basic) | $1.53 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| EPS (Diluted) | $1.50 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| Shares (Basic) | 41,402,997 | 40,850,446 | 40,315,068 | 38,997,649 | · | · | · | · | · | |
| Shares (Diluted) | 42,418,644 | 40,850,446 | 40,566,901 | 38,997,649 | · | · | · | · | · | |
| EBITDA | $-15M | · | $-16M | $-41M | · | $-12M | $-15M | · | · |
Stato Patrimoniale 23
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $54M | $9M | $40M | · | $19M | $3M | $5M | $4M | |
| Short-term Investments | $5M | $3M | · | · | $8M | $3M | · | $5M | · | |
| Prepaid Expense | $3M | $1M | $537.0K | $1M | · | $611.0K | $1M | $574.0K | · | |
| Current Assets | $133M | $143M | $163M | $157M | $148M | $41M | $33M | $31M | · | |
| PP&E (Net) | $586.0K | $698.0K | $873.0K | $815.0K | $388.0K | $99.0K | $24.0K | $17.0K | · | |
| Other Non-current Assets | $44.0K | $32.0K | $27.0K | · | · | · | · | · | · | |
| Total Assets | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Accounts Payable | $443.0K | $789.0K | $551.0K | $4M | $5M | $2M | $3M | $2M | · | |
| Accrued Liabilities | $1M | $402.0K | $605.0K | · | · | · | · | · | · | |
| Short-term Debt | $652.0K | $329.0K | $51M | · | · | · | $3M | $2M | · | |
| Current Liabilities | $19M | $6M | $53M | $6M | $7M | $5M | $5M | $5M | · | |
| Capital Leases | $540.0K | $156.0K | $342.0K | $647.0K | $370.0K | $31.0K | · | · | · | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | $60.0K | $63.0K | · | · | $211.0K | $271.0K | $313.0K | · | |
| Long-term Debt | · | · | · | $25.0K | $12M | · | $10M | $11M | · | |
| Total Debt | · | · | $51M | · | · | · | $3M | · | · | |
| Common Stock | $472.0K | $480.0K | $485.0K | $476.0K | $459.0K | $284.0K | $208.0K | $207.0K | · | |
| Paid-in Capital | · | · | · | $314M | $293M | $125M | · | · | · | |
| Retained Earnings | $-123M | $-177M | $-158M | $-163M | $-127M | $-93M | $-81M | $-69M | · | |
| AOCI | · | · | · | · | · | · | · | $702.0K | · | |
| Stockholders' Equity | $200M | $145M | $164M | $152M | $166M | $33M | $19M | $31M | $19M | |
| Liabilities + Equity | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Shares Outstanding | 39,275,006 | 39,920 | 40,339,000 | 39,564,000 | 38,158 | 23,675,530 | 17,383,359 | 17,369,875 | · |
Flusso di cassa 12
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | $4M | $12M | · | $465.0K | $808.0K | $2M | $2M | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-10M | $-28M | · | $-12M | $-13M | $-15M | $-6M | |
| CapEx | $9.0K | $18.0K | $254.0K | $496.0K | · | $82.0K | $15.0K | $5.0K | $7.0K | |
| Investing Cash Flow | $5M | $106M | $-73M | $30M | · | $5M | $11M | $-7M | $4M | |
| Stock Issued | · | · | $2M | $12M | · | · | · | · | · | |
| Stock Repurchased | $5M | $2M | · | · | · | · | · | · | · | |
| Net Stock Activity | $-5M | · | $2M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-5M | $-52M | $52M | $11M | · | $24M | · | $23M | $2M | |
| Net Change in Cash | $-8M | $45M | $-31M | $13M | · | $16M | $-2M | $1M | $62.0K | |
| Taxes Paid | · | $2M | · | $2M | · | · | $300.0K | · | $400.0K | |
| Free Cash Flow | $-9M | · | $-11M | $-28M | · | $-13M | $-13M | · | · |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.65% | · | · | · | · | · | · | · | · | |
| Operating Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| Net Margin | 3202.5% | · | 412.3% | -1397.1% | · | -424.8% | -531.1% | · | · | |
| Pretax Margin | 3766.2% | · | 379.7% | · | · | -424.8% | -520.0% | · | · | |
| EBITDA Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| ROA | 33.2% | · | 2.9% | -22.2% | · | -29.0% | -35.0% | · | · | |
| ROE | 37.0% | · | 3.5% | -23.7% | · | -47.0% | -70.1% | · | · | |
| ROIC | -6.4% | · | · | · | · | · | -67.6% | · | · |
Liquidità e Solvibilità 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | · | 3.1 | 27.3 | · | 8.9 | 6.3 | · | · | |
| Quick Ratio | 2.7 | · | 1.3 | 0.7 | · | 5.0 | 1.3 | · | · | |
| Debt / Equity | · | · | 0.3 | · | · | · | 0.1 | · | · | |
| Interest Coverage | · | · | -7.7 | · | · | · | · | · | · |
Efficienza 1
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | 0.1 | 0.1 | · | · |
Tassi di Crescita 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -50.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -9.6% | · | · | · | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $3M | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Net Income TTM | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| Market Cap | $112M | · | $93M | $476M | · | $83M | $58M | · | · | |
| Enterprise Value | · | · | $77M | · | · | · | $53M | · | · | |
| P/E | 1.9 | -5.0 | 16.5 | -12.8 | · | · | · | · | · | |
| P/S | 56.0 | · | 69.5 | 176.1 | · | 30.5 | 21.4 | · | · | |
| P/B | 0.6 | · | 0.6 | 3.1 | · | 2.5 | 3.0 | · | · | |
| P / Tangible Book | 0.6 | 0.7 | 0.6 | 3.1 | · | 2.5 | · | · | · | |
| P / Cash Flow | -12.2 | · | -9.1 | -17.0 | · | -6.6 | -4.5 | · | · | |
| P / FCF | -12.2 | · | -8.8 | -16.8 | · | -6.6 | -4.5 | · | · | |
| EV / EBITDA | · | · | -4.9 | · | · | · | -3.6 | · | · | |
| EV / FCF | · | · | -7.3 | · | · | · | -4.1 | · | · | |
| EV / Revenue | · | · | 57.8 | · | · | · | 19.8 | · | · | |
| Earnings Yield | 52.6% | -19.8% | 6.1% | -7.8% | · | · | · | · | · |
Conto Economico 17
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | · | · | $2M | · | · | · | · | $0 | · | $674.0K | $666.0K | $681.0K | $682.0K | |
| Cost of Revenue | · | · | $0 | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | · | · | $0 | · | · | $13.0K | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | · | $2M | $2M | $1M | $1M | $2M | $1M | $2M | $1M | $1M | $2M | $957.0K | $2M | $4M | $7M | $5M | |
| SG&A Expense | $3M | $2M | $4M | $1M | $1M | $2M | $2M | $847.0K | $2M | $2M | $2M | $3M | $2M | $1M | $3M | $3M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $11.0K | |
| Operating Income | $-3M | $-4M | $-6M | $-2M | $-2M | $-4M | $-4M | $-3M | $-3M | $-3M | $-4M | $-3M | $-4M | $-5M | $-10M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $592.0K | · | $826.0K | · | · | · | · | |
| Other Non-op | $-4.0K | $-100.0K | $-74M | $61M | · | $-143.0K | $-2M | $-15M | $14M | $4M | $-4M | $435.0K | $2M | $2M | $1M | $1M | |
| Pretax Income | $102M | $49M | $10M | $59M | $13M | $-7M | $-10M | $-19M | $11M | $2M | $13M | $-3M | $-1M | · | $-9M | $-7M | |
| Income Tax | $23M | $11M | $-212.0K | $11M | $-126.0K | $584.0K | $416.0K | $1M | $2M | · | · | · | · | · | $0 | $100.0K | |
| Net Income | $78M | $38M | $10M | $48M | $13M | $-8M | $-10M | $-20M | $9M | $2M | $13M | $-3M | $-1M | $-3M | $-8M | $-7M | |
| EPS (Basic) | $1.90 | $0.94 | $0.24 | $1.16 | $0.32 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| EPS (Diluted) | $1.84 | $0.91 | $0.25 | $1.13 | $0.31 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| Shares (Basic) | 41,040,479 | 40,773,866 | -83,325,572 | 41,756,301 | 41,743,486 | 41,228,782 | -81,842,111 | 40,896,845 | 40,959,759 | 40,835,953 | -80,397,680 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| Shares (Diluted) | 42,501,252 | 41,970,186 | -84,194,067 | 42,774,504 | 42,609,425 | 41,228,782 | -83,201,413 | 40,896,845 | 41,591,007 | 41,564,007 | -80,145,847 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| EBITDA | $-3M | $-4M | · | $-2M | $-2M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-4M | $-5M | · | $-8M |
Stato Patrimoniale 22
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $13M | $46M | $52M | $16M | · | $54M | · | $10M | $19M | · | · | · | · | $40M | · | |
| Short-term Investments | $846.0K | $5M | $5M | $5M | $2M | $4M | $3M | $57M | $66M | $78M | · | $49.4K | $943.0K | $2M | · | $5M | |
| Prepaid Expense | $2M | $2M | $3M | $1M | $1M | $832.0K | $1M | $474.0K | $533.0K | $501.0K | $537.0K | $666.0K | $769.0K | · | $1M | · | |
| Current Assets | $53M | $68M | $133M | $136M | $99M | $131M | $143M | $143M | $153M | $177M | $163M | $176M | $151M | $155M | $157M | $160M | |
| PP&E (Net) | $532.0K | $561.0K | $586.0K | $614.0K | $645.0K | $671.0K | $698.0K | $718.0K | $765.0K | $819.0K | $873.0K | $923.0K | $945.0K | $977.0K | $815.0K | $535.0K | |
| Other Non-current Assets | $49.0K | $46.0K | $44.0K | $40.0K | $38.0K | $32.0K | $32.0K | · | · | · | $27.0K | · | · | · | · | · | |
| Total Assets | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Accounts Payable | $374.0K | $481.0K | $443.0K | $560.0K | $715.0K | $509.0K | $789.0K | $5M | $3M | $1M | $551.0K | $3M | $828.0K | $4M | $4M | $4M | |
| Accrued Liabilities | $1M | $1M | $1M | $585.0K | $841.0K | $800.0K | $402.0K | · | · | · | $605.0K | · | · | · | · | · | |
| Short-term Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | $51M | $75M | $3.0K | $1.0K | · | · | |
| Current Liabilities | $11M | $11M | $19M | $6M | $4M | $5M | $6M | $5M | $4M | $34M | $53M | $78M | $1M | $5M | $6M | $7M | |
| Capital Leases | $484.0K | $493.0K | $540.0K | $589.0K | $648.0K | $120.0K | $156.0K | $186.0K | $236.0K | $272.0K | $342.0K | $389.0K | $488.0K | $564.0K | $647.0K | $672.0K | |
| Deferred Tax | $40M | $18M | $8M | $8M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $60.0K | $60.0K | $60.0K | · | $63.0K | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $75M | · | · | · | $5M | |
| Total Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | · | $75M | $3.0K | $1.0K | · | · | |
| Common Stock | $495.0K | $491.0K | $472.0K | $490.0K | $491.0K | $491.0K | $480.0K | $484.0K | $488.0K | $487.0K | $485.0K | $484.0K | $484.0K | $481.0K | $476.0K | $470.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | $319M | $317M | · | $308M | |
| Retained Earnings | $-7M | $-85M | $-123M | $-123M | $-171M | $-184M | $-177M | $-166M | $-147M | $-156M | $-158M | $-171M | $-168M | $-166M | $-163M | $-155M | |
| Stockholders' Equity | $317M | $238M | $200M | $203M | $155M | $141M | $146M | $156M | $177M | $167M | $164M | $149M | $152M | $151M | $152M | $154M | |
| Liabilities + Equity | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Shares Outstanding | 41,314,211 | 40,926,081 | 39,275,006 | 40,838,226 | 40,845,087 | 40,850,455 | 39,919,545 | 40,209,575 | 40,628,924 | 40,519,160 | 40,338,979 | 40,282,688 | 40,219,396 | 39,969,979 | 39,563,888 | 39,113,236 |
Flusso di cassa 12
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $719.0K | $800.0K | $2M | $1M | $301.0K | $1M | $1M | $1M | $852.0K | $2M | $173.0K | $3M | $3M | |
| Deferred Tax | $22M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-200.0K | $-3M | $-466.0K | $-2M | $-4M | $-4M | $-2M | $-7M | $2M | $-1M | $-1M | $-694.0K | $-3M | $-6M | $-8M | $-2M | |
| CapEx | $2.0K | $5.0K | $2.0K | $0 | $4.0K | $3.0K | $11.0K | $5.0K | $0 | $2.0K | $3.0K | $32.0K | $20.0K | $199.0K | $308.0K | $121.0K | |
| Investing Cash Flow | $4M | $-19M | $-2M | $38M | $-55M | $24M | $15M | $-34M | $95M | $30M | $30M | $-75M | $-15M | $-13M | $11M | $1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $-2.0K | $0 | $2M | $4M | $-3M | |
| Stock Repurchased | · | · | $4M | $361.0K | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $78.0K | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-2M | $-10M | $-4M | $-361.0K | · | · | $-1M | $-1M | $-31M | $-19M | $-25M | $75M | $0 | $2M | $4M | $4M | |
| Net Change in Cash | $2M | $-33M | $-6M | $36M | $-59M | $20M | $12M | $-43M | $66M | $10M | $4M | $-1M | $-17M | $-16M | $7M | $3M | |
| Taxes Paid | · | · | · | $-7M | · | · | · | · | · | · | · | $527.0K | $3M | $308.0K | · | $167.0K | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · | · | $-1M | · | · | · | $-6M | · | · |
Redditività 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 0.65% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| Net Margin | · | · | · | · | · | -382.1% | · | · | · | · | · | · | -177.2% | -542.2% | · | -1063.5% | |
| Pretax Margin | · | · | · | · | · | -352.9% | · | · | · | · | · | · | · | · | · | -1048.8% | |
| EBITDA Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| ROA | 29.4% | 18.4% | · | 25.1% | 7.7% | -4.3% | · | -9.9% | 5.4% | 0.85% | · | -1.6% | -0.75% | -2.2% | · | -5.9% | |
| ROE | 33.1% | 20.2% | · | 26.9% | 8.0% | -5.0% | · | -12.8% | 5.6% | 0.97% | · | -2.1% | -0.78% | -2.3% | · | -6.5% | |
| ROIC | -0.67% | -1.2% | · | -0.97% | -1.6% | -3.5% | · | -2.1% | -1.5% | · | · | · | · | · | · | -5.4% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 6.5 | · | 22.2 | 26.8 | 23.9 | · | 27.1 | 41.1 | 5.3 | · | 2.2 | 141.5 | 31.2 | · | 24.5 | |
| Quick Ratio | 1.5 | 1.7 | · | 9.3 | 4.8 | 0.7 | · | 10.9 | 20.4 | 2.9 | · | 0.0 | 0.9 | 0.5 | · | 0.8 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.2 | · | 0.5 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -5.0 | · | -3.5 | · | · | · | · |
Efficienza 1
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 |
Valutazione (TTM) 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Net Income TTM | $178M | $92M | · | $34M | $-5M | $-17M | · | $-12M | $6M | $-6M | · | $-15M | $-22M | $-32M | · | $-36M | |
| Market Cap | $199M | $139M | · | $108M | $92M | $87M | · | $98M | $104M | $118M | · | $105M | $144M | $87M | · | $253M | |
| Enterprise Value | · | · | · | $51M | $74M | · | · | · | · | $54M | · | · | · | · | · | · | |
| P/E | 1.1 | 1.6 | · | 3.4 | -16.1 | -5.2 | · | -8.1 | 17.1 | -19.5 | · | -261.0 | 10.5 | 3.4 | · | 7.0 | |
| P/S | · | · | · | · | · | · | · | 36.4 | 38.7 | 43.9 | · | 39.0 | 53.4 | 32.4 | · | 94.0 | |
| P/B | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Tangible Book | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Cash Flow | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.2 | · | · | · | -15.7 | · | · | |
| P / FCF | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.1 | · | · | · | -15.2 | · | · | |
| EV / EBITDA | · | · | · | -20.9 | -29.9 | · | · | · | · | -18.2 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -36.6 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 20.0 | · | · | · | · | · | · | |
| Earnings Yield | 87.1% | 63.5% | · | 29.2% | -6.2% | -19.2% | · | -12.3% | 5.8% | -5.1% | · | -0.38% | 9.5% | 29.4% | · | 14.3% | |
| Payout Ratio | · | 27.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $2M | — | $1M | $3M | — |
| Margine Lordo % | 0.65% | — | — | — | — |
| Margine Operativo % | -754.4% | — | -1176.8% | -1502.0% | — |
| Utile netto | $64M | $-19M | $5M | $-37M | — |
| EPS Diluito | $1.50 | $-0.48 | $0.14 | $-0.94 | — |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | — | — | 0.3 | — | — |
| Rapporto corrente | 7.0 | — | 3.1 | 27.3 | — |
| Quick Ratio | 2.7 | — | 1.3 | 0.7 | — |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-9M | — | $-11M | $-28M | — |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 88 filer · $64.4M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 30 (+13 vs trimestre precedente) | 8 (0 vs trimestre precedente) | 19 (-1 vs trimestre precedente) | 19 (+5 vs trimestre precedente) | -209K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Aquamarine Financial (Cayman) Ltd | $12.083.562 | 2.512.175 | 18,77% | Azioni |
| Gem Investment Advisors, LLC | $9.614.238 | 1.998.802 | 14,94% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $9.189.697 | 1.910.540 | 14,28% | Azioni |
| Murchinson Ltd. | $6.206.314 | 1.290.294 | 9,64% | Azioni |
| SB Capital Management Inc | $5.415.000 | 1.900.000 | 8,41% | Azioni |
| BML Capital Management, LLC | $4.166.754 | 866.269 | 6,47% | Azioni |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.783.249 | 578.638 | 4,32% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $2.162.008 | 449.482 | 3,36% | Azioni |
| STATE STREET CORP | $1.164.501 | 242.100 | 1,81% | Azioni |
| Rathbones Group PLC | $1.120.816 | 233.018 | 1,74% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.105.732 | 229.882 | 1,72% | Azioni |
| GOLDMAN SACHS GROUP INC | $950.908 | 197.694 | 1,48% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $884.078 | 183.800 | 1,37% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $784.896 | 163.180 | 1,22% | Azioni |
| STRS OHIO | $643.578 | 133.800 | 1,00% | Azioni |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $495.247 | 102.962 | 0,77% | Azioni |
| JANE STREET GROUP, LLC | $470.606 | 97.839 | 0,73% | Azioni |
| Hillsdale Investment Management Inc. | $429.533 | 89.300 | 0,67% | Azioni |
| RITHOLTZ WEALTH MANAGEMENT | $405.709 | 84.347 | 0,63% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $402.280 | 83.634 | 0,63% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $287.518 | 59.775 | 0,45% | Azioni |
| XTX Topco Ltd | $240.130 | 49.923 | 0,37% | Azioni |
| Nuveen, LLC | $223.203 | 46.404 | 0,35% | Azioni |
| DEUTSCHE BANK AG\ | $159.682 | 33.198 | 0,25% | Azioni |
| PRELUDE CAPITAL MANAGEMENT, LLC | $157.350 | 32.713 | 0,24% | Azioni |
| BAILARD, INC. | $156.219 | 32.478 | 0,24% | Azioni |
| RHUMBLINE ADVISERS | $147.281 | 30.621 | 0,23% | Azioni |
| Bank of New York Mellon Corp | $143.016 | 29.733 | 0,22% | Azioni |
| ALGERT GLOBAL LLC | $139.288 | 28.958 | 0,22% | Azioni |
| WELLS FARGO & COMPANY/MN | $137.080 | 28.499 | 0,21% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $121.246 | 25.207 | 0,19% | Azioni |
| CITADEL ADVISORS LLC | $120.250 | 25.000 | 0,19% | Opzione Call |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $107.263 | 22.300 | 0,17% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $105.151 | 21.861 | 0,16% | Azioni |
| PNC Financial Services Group, Inc. | $101.972 | 21.200 | 0,16% | Azioni |
| Redwood Family Wealth LLC | $99.783 | 20.745 | 0,16% | Azioni |
| BANK OF AMERICA CORP /DE/ | $91.621 | 19.048 | 0,14% | Azioni |
| MORGAN STANLEY | $87.994 | 18.294 | 0,14% | Azioni |
| Sage Capital Management, LLC | $86.474 | 17.977 | 0,13% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $75.378 | 15.671 | 0,12% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $67.811 | 14.098 | 0,11% | Azioni |
| CITIGROUP INC | $66.590 | 13.844 | 0,10% | Azioni |
| JPMORGAN CHASE & CO | $65.461 | 14.108 | 0,10% | Azioni |
| Invesco Ltd. | $65.272 | 13.570 | 0,10% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $61.650 | 12.817 | 0,10% | Azioni |
| Engineers Gate Manager LP | $61.077 | 12.698 | 0,09% | Azioni |
| Altshuler Shaham Ltd | $53.925 | 11.211 | 0,08% | Azioni |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $52.096 | 12.895 | 0,08% | Azioni |
| Glass Jacobson Investment Advisors llc | $50.698 | 10.540 | 0,08% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $50.115 | 10.419 | 0,08% | Azioni |
| MARSHALL WACE, LLP | $50.024 | 10.400 | 0,08% | Azioni |
| Hudson Bay Capital Management LP | $49.375 | 10.265 | 0,08% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $47.706 | 9.918 | 0,07% | Azioni |
| Steward Partners Investment Advisory, LLC | $42.453 | 8.826 | 0,07% | Azioni |
| BARCLAYS PLC | $27.917 | 5.804 | 0,04% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $25.974 | 5.400 | 0,04% | Azioni |
| NORTHERN TRUST CORP | $25.503 | 5.302 | 0,04% | Azioni |
| Tower Research Capital LLC (TRC) | $23.218 | 4.827 | 0,04% | Azioni |
| OSAIC HOLDINGS, INC. | $20.283 | 4.217 | 0,03% | Azioni |
| FEDERATED HERMES, INC. | $19.221 | 3.996 | 0,03% | Azioni |
| N.E.W. Advisory Services LLC | $16.495 | 3.429 | 0,03% | Azioni |
| Legal & General Group Plc | $15.979 | 3.322 | 0,02% | Azioni |
| CITADEL ADVISORS LLC | $15.565 | 3.236 | 0,02% | Azioni |
| Ameritas Investment Partners, Inc. | $14.853 | 3.088 | 0,02% | Azioni |
| HUNTINGTON NATIONAL BANK | $14.440 | 3.002 | 0,02% | Azioni |
| Pioneer Family Office, LLC | $14.430 | 3.000 | 0,02% | Azioni |
| Russell Investments Group, Ltd. | $13.088 | 2.721 | 0,02% | Azioni |
| UBS Group AG | $12.987 | 2.700 | 0,02% | Azioni |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $7.576 | 1.575 | 0,01% | Azioni |
| MetLife Investment Management, LLC | $7.037 | 1.463 | 0,01% | Azioni |
| BlackRock, Inc. | $6.768 | 1.407 | 0,01% | Azioni |
| ROYAL BANK OF CANADA | $6.000 | 1.246 | 0,01% | Azioni |
| MCF Advisors LLC | $5.162 | 1.073 | 0,01% | Azioni |
| Caitlin John, LLC | $4.810 | 1.000 | 0,01% | Azioni |
| McIlrath & Eck, LLC | $3.400 | 1.000 | 0,01% | Azioni |
| Sterling Capital Management LLC | $3.300 | 686 | 0,01% | Azioni |
| IFP Advisors, Inc | $2.405 | 500 | 0,00% | Azioni |
| PROEQUITIES, INC. | $2.310 | 1.000 | 0,00% | Azioni |
| Golden State Wealth Management, LLC | $1.458 | 303 | 0,00% | Azioni |
| JONES FINANCIAL COMPANIES LLLP | $999 | 214 | 0,00% | Azioni |
| HRT FINANCIAL LP | $469 | 97.582 | 0,00% | Azioni |
| FMR LLC | $332 | 69 | 0,00% | Azioni |
| SBI Securities Co., Ltd. | $284 | 59 | 0,00% | Azioni |
| PRICE T ROWE ASSOCIATES INC /MD/ | $135 | 27.909 | 0,00% | Azioni |
| TrinityBridge Ltd | $56 | 11.675 | 0,00% | Azioni |
| HARBOUR INVESTMENTS, INC. | $48 | 10 | 0,00% | Azioni |
| Caitong International Asset Management Co., Ltd | $29 | 6 | 0,00% | Azioni |
| ACADIAN ASSET MANAGEMENT LLC | $8 | 1.691 | 0,00% | Azioni |
Insider aziendali 30 insider · 13 dirigenti · 16 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Nadav Kidron | President and CEO | 30 Marzo 2026 F | 3.422.243 | 0 | 0 | $0 |
| Avraham Gabay | Chief Financial Officer | 01 Luglio 2026 S | 671.785 | 0 | 1 | $-330.854 |
| David Silberman | Chief Financial Officer | 04 Gennaio 2024 A | 366.500 | 0 | 0 | $0 |
| Hilla Eisenberg | CFO, Treasurer and Secretary | 26 Febbraio 2019 A | — | 0 | 0 | $0 |
| Yifat Hen Zommer | CFO, Treasurer and Secretary | 30 Giugno 2017 A | 46.560 | 0 | 0 | $0 |
| Chaime Orlev | CFO, Treasurer and Secretary | 12 Ottobre 2008 A | — | 0 | 0 | $0 |
| Joshua Hexter | COO & CBO | 02 Luglio 2026 M | 1.073.384 | 0 | 1 | $-611.020 |
| Miriam Kidron | Chief Scientific Officer | 30 Marzo 2026 F | 1.133.138 | 0 | 0 | $0 |
| Netanel Derovan | Chief Legal Officer | 26 Maggio 2023 A | 149.500 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 03 Gennaio 2023 S | 126.143 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 03 Gennaio 2022 A | 109.468 | 0 | 0 | $0 |
| Mark Daniel Hasleton | VP Business Development | 26 Febbraio 2019 A | — | 0 | 0 | $0 |
| Ronald Edward Law | Chief Strategy Officer | 20 Marzo 2017 A | — | 0 | 0 | $0 |
| Yehuda Reznick | Direttore | 31 Dicembre 2025 A | 105.180 | 0 | 0 | $0 |
| Daniel Aghion | Direttore | 31 Dicembre 2025 A | 113.441 | 0 | 0 | $0 |
| Benjamin Shapiro | Direttore | 31 Dicembre 2025 A | 123.220 | 0 | 0 | $0 |
| Arie Mayer | Direttore | 31 Dicembre 2025 A | 168.009 | 0 | 0 | $0 |
| Leonard Sank | Direttore | 05 Giugno 2025 A | 134.531 | 0 | 0 | $0 |
| Yadin Rozov | Direttore | 04 Gennaio 2024 A | 155.320 | 0 | 0 | $0 |
| Kevin Rakin | Direttore | 21 Marzo 2022 S | 46.661 | 0 | 0 | $0 |
| Aviad Friedman | Direttore | 03 Gennaio 2022 G | 0 | 0 | 0 | $0 |
| Gao Xiaoming | Direttore | 08 Gennaio 2020 A | — | 0 | 0 | $0 |
| David Mark Slager | Direttore | 15 Aprile 2019 A | 1.316.328 | 0 | 0 | $0 |
| Xiaopeng Li | Direttore | 02 Agosto 2017 P | 206.350 | 0 | 0 | $0 |
| Harold Jacob | Direttore | 10 Marzo 2016 S | 16.396 | 0 | 0 | $0 |
| Michael Berelowitz | Direttore | 09 Dicembre 2015 S | 22.896 | 0 | 0 | $0 |
| Gerald M Ostrov | Direttore | 23 Febbraio 2015 A | 24.896 | 0 | 0 | $0 |
| REGALS CAPITAL MANAGEMENT LP | Proprietario del 10% | 23 Dicembre 2015 X | 1.186.823 | 0 | 0 | $0 |
| Zeev Bronfeld | Proprietario del 10% | 27 Settembre 2011 S | 5.808.517 | 0 | 0 | $0 |
| Michael Young | — | 27 Maggio 2004 S | 0 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 9 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 22 Luglio 2026 | 3,30% | Modifica | — | SEC |
| Nadav Kidron ×8 depositi | 28 Agosto 2025 | 7,60% | Modifica | — | SEC |
| Regals Capital Management LP, Regals Fund LP, David M. Slager ×2 depositi | 20 Luglio 2018 | — | Deposito iniziale | — | SEC |
| Hefei Tianhui Incubator of Technologies Co., Ltd | 06 Gennaio 2016 | — | Deposito iniziale | — | SEC |
| Leonard Sank | 15 Dicembre 2014 | — | Deposito iniziale | Investimento passivo | SEC |
| Miriam Kidron ×2 depositi | 03 Febbraio 2014 | — | Deposito iniziale | — | SEC |
| Zeev Bronfeld | 06 Marzo 2006 | — | Deposito iniziale | Investimento passivo | SEC |
| Persona segnalante non divulgata | 10 Giugno 2004 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 10 Giugno 2004 | — | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 14 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 114.970 SH | 08 Agosto 2026 | Giornaliero |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 7.046 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 29.637 SH | 08 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | 0,01% | 315.439 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 28.155 NS | 31 Maggio 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 621.705 SH | 08 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,00% | 26.896 NS | 30 Aprile 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.523 NS | 30 Aprile 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 36.536 NS | 30 Aprile 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 4.152 NS | 31 Maggio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3.431 NS | 30 Aprile 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 196.765 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.480 SH | 08 Agosto 2026 | Giornaliero |
| DXUV · Dimensional ETF Trust | 0,00% | 4 NS | 30 Aprile 2026 | N-PORT |